This letter refutes the “overdiagnosis” narrative, blaming the stimulant shortage on DEA regulatory failures, clinical constraints, and recognition of historical underdiagnosis. By concluding that ...
This post is in response to The NIMH Withdraws Support for DSM-5 By Christopher Lane Ph.D. It is the beginning of the end. Just weeks before the publication of the fifth revision, the NIMH leadership ...
The authors of “Overdiagnosis of Adult ADHD Is Exacerbating the Stimulant Shortage” reply to a letter to the editor. We welcome the input and opportunity for discussion. There is much on which we can ...